期刊文献+

参苓养心汤治疗慢性心力衰竭的疗效及不良反应观察 被引量:4

Observation on the Efficacy and Adverse Reactions of Shenling Yangxin Decoction in the Treatment of Chronic Heart Failure
暂未订购
导出
摘要 目的研究参苓养心汤应用于慢性心力衰竭治疗的效果分析。方法选取2018年1月至2019年1月我院的慢性心力衰竭90例患者,给予常西药治疗的45例设为对照组,将给予西药联合参苓养心汤治疗的45例设为研究组,比较两组患者的临床疗效。结果治疗后,研究组患者临床治疗的总有效率97.77%明显高于对照组的80.00%,差异具有统计学意义(P<0.05)但两组患者都没有出现显著不良反应。结论参苓养心汤应用于慢性心力衰竭患者的临床治疗中对患者的心功能改善效果明显,且安全性较高。 Objective To study the effect of Shenling Yangxin Decoction on chronic heart failure.Methods Ninety patients with chronic heart failure in our hospital from January 2018 to January 2019 were selected.45 patients treated with Changxi medicine were set as the control group,and 45 patients treated with western medicine combined with Shenling Yangxin Decoction were set as the study.Group,compare the clinical efficacy of the two groups of patients.Results After treatment,the total effective rate of clinical treatment in the study group was 97.77%,which was significantly higher than 80.00%in the control group.The difference was statistically significant(P<0.05),but no significant adverse reactions occurred in the two groups of patients.Conclusion Shenling Yangxin Decoction can improve the cardiac function of patients with chronic heart failure in clinical treatment,and it has high safety.
作者 刘吉 孙晓皎 LIU Ji;SUN Xiao-jiao(Department of Cardiology,Shenyang Tiexi District Central Hospital,Shenyang 110021,China)
出处 《中国医药指南》 2020年第9期20-21,共2页 Guide of China Medicine
关键词 参苓养心汤 慢性心力衰竭 心功能 活动耐力 Shenling Yangxin Decoction Chronic heart failure Heart function Active endurance
  • 相关文献

参考文献5

二级参考文献95

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3828

同被引文献38

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部